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Abstract 
BACKGROUND: Obesity is considered associated with an increase of resistin levels that plays a role in the 
regulation of energy and maintaining fasting blood glucose. Polymorphism of resistin is thought to be correlated 
with the levels of resistin and insulin resistance. 
AIM: This study aimed to examine the association of +299G > A and -420C > G resistin (RETN) gene with resistin 
level and insulin resistance in obese people of Indonesia. 
METHODS: We examined 142 healthy unrelated subjects consisting of 71 obese and 71 controls. Fasting blood 
glucose was measured by the enzymatic method while the resistin and insulin levels were measured by Elisa 
method. Insulin resistance was calculated by HOMA-IR index. Polymorphisms of RETN genes were examined by 
the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method, and the data 
was tested. The data were correlated with Kruskal Wallis continue logistic regression and simple linear regression 
RESULTS: In the obese group, there was an increased level of insulin (17.74 vs 11.27 mU/L) and insulin 
resistance (HOMA-IR 3.9 vs 1.46) compared to the control group. Polymorphism of +299G > A was associated 
with insulin resistance (GA and GA + AA genotype significantly different compare GG genotype with P < 0.001). 
Resistin level was negatively correlated with insulin level (P = 0.017).  
CONCLUSION: In this study, polymorphism of +299G > A was identified as a risk factor for insulin resistance, and 
there was a significant association of serum resistin level with insulin level in the population of Indonesia. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Obesity is a chronic inflammatory state 
characterised by elevated pro-inflammatory 
adipokines [1]. Adipose tissue in obese subjects is 
characterised by increased macrophages infiltration, 
which is thought to play a role in the pathogenesis of 
pro-inflammatory events [2]. Resistin is one of the pro-
inflammatory adipokines and has been associated 
with obesity. The expression of resistin increases with 
adipose differentiation [3]. Resistin plays an important 
role in regulating energy, glucose and fat homeostasis 
by modulating hepatic insulin action with single 
nucleotide polymorphisms (SNPs) [4]. 
Two-thirds of plasma resistin variations are 
influenced by genetics [5]. Resistin gene is on the 
19p3.2 chromosome, consists of 4 exons and 3 
introns. This gene is polymorphic in SNPs of 
promoters, introns and 3'UTR. The SNP promoter -
420C/G (rs1862513) is associated with obesity [6], 
insulin sensitivity and resistance, elevated blood sugar 
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levels and lipid profile [7], [8]. However, results from 
some studies in various populations did not show any 
association of lipid profiles [5] and obesity [3]. The 
effect of SNP -420C > G on its expression was 
estimated due to its effect on the binding of a 
transcription factor on RETN promoter [8]. Research 
on the +299 RETN gene polymorphism showed 
+299G > A polymorphism was significantly associated 
with elevated plasma resistin [9]. Polymorphism of 
+299G > A RETN gene in a cohort study showed that 
A allele is associated with increased risk of Metabolic 
Syndrome [10], but in a study of Iranian patients with 
Gestational Diabetes Mellitus, this allele was not 
significantly different with controls [11]. 
This study aimed to correlate the 
polymorphisms of +299G > A (rs3745367) and -420C 
> G (rs1862513) RETN gene in obese Indonesian 
population with levels of resistin and insulin 
resistance. 
 
 
Methods 
 
This research was a case-control study 
involving 142 healthy participants 18-40 years old, 
consisting of 71 subjects with Body Mass Index (BMI) 
≥ 25 kg/m
2 
as the obese group and 71 subjects with 
BMI 18.50 to 23 Kg/m
2 
as the control group. Samples 
were taken with consecutive sampling.
 
All subjects had normal blood glucose 
concentrations. Subjects who consumed anti-diabetes 
and anti-inflammatory drugs were excluded from this 
research. All subjects agreed to participate and signed 
an informed consent form. This study was by the 
Helsinki Declaration and had approval from the 
Medical and Health Research Ethics Committee of the 
Faculty of Medicine, Public Health and Nursing, 
Universitas Gadjah Mada, Yogyakarta, Indonesia, 
number: KE/FK/569/EC/2015. 
 
Samples 
Blood was drawn from subjects after fasting 8 
hours, and the plasma was separated from buffy coat. 
Fasting blood glucose, insulin and resistin levels were 
measured from plasma. DNA was isolated from buffy 
coat for determination of RETN polymorphism. Blood 
glucose was determined by the enzymatic method 
with the Dyasis kit. Resistin and insulin levels were 
measured with Elisa kit (Elabscience catalogue 
number: E-EL-H1213). Determination of insulin 
resistance was calculated by the following formula: 
HOMA-IR = {insulin (µU/mL) X glucose 
(mmol/L)}/22.5  
HOMA-IR > 2.0 was grouped as glucose 
intolerance [12]. 
Isolation of DNA was done with Promega kit, 
and genotyping of resistin genes was examined with 
the Polymerase Chain Reaction-Restriction Fragment 
Length Polymorphism (PCR-RFLP) methods. 
 
Genotyping of +299G > A RETN gene 
DNA was amplified with forwarding primer 
5’GAGAGGATCCAGGAGGTCG 3’ and reverse 
primer 5’GTGAGACCAAACGGTCCCT 3’. The PCR 
was done as follows: 
Denaturation at 95°C for 5 min, pre-annealing 
at 59°C 1 min, elongation at 72°C for 2 min, then 35 
cycles of 30 s at 95°C, 30 s at 59°C and 1 min 15 s at 
72°C, and elongation at 72°C for 10 min. Product of 
PCR was 373 base pair (bp) then digested by AluI 
enzymes (MBI-Fermentas, United Kingdom) and 
separated by electrophoresis with 2% agarose gel and 
stained with ethidium bromide [13]. 
 
Genotyping of -420G > C RETN gene 
DNA was amplified with forwarding primer 5'- 
TGTCATTCTCACCCAGAGACA-3' and reversed 
primer 5'-TGGGCTCAGCTAACCAAATC-3'. The PCR 
method was as follows: denaturation at 95°C for 7 
min, pre-annealing at 61°C for 1 min, elongation at 
72°C for 2 min followed by 35 cycles of 30 s at 95°C, 
30 s at 64°C and for 1 min 15 s at 72 °C and final 
elongation for 10 min at 72°C. The 534 bp PCR 
products were digested with BbsI enzyme at 37°C for 
16 hours. The digestion products were separated by 
electrophoresis with 2% agarose gel. The G allele was 
visualised at 327 bp and C allele at 207 bp [14]. 
 
Statistical Analysis 
All statistical analyses were performed using 
SPSS 17 software. Variables that were not normally 
distributed were presented as mean with Interquartile 
Range (IQR). The associations of +299 G > A and -
420 C > G RETN with resistin level were analysed 
with the Kruskal Wallis test. The associations of 
+299G > A and -420C > G RETN with insulin 
resistance were analysed with logistic regression. 
Serum resistin level associated with BMI and insulin 
resistance parameters were analysed with simple 
linear regression, and the results were considered 
significantly different when p < 0.05. 
 
 
Results 
 
Characteristics of subjects 
The BMI, insulin level and HOMA-IR in the 
obese group were higher and significantly different 
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compared with the control group (p < 0.05) (Table 1). 
Table 1: Characteristic of subjects  
Variable Obese (n = 71) Control (n = 71) P 
Sex 
Male 
Female 
 
30 (42.3%) 
41 (57.7%) 
 
25 (35.2%) 
46 (64.8%) 
 
0.389 
Age (Year) 25.8 ± 5.9 25.4 ± 5.7 0.545 
BMI (kg/m
2
) 31.9 ± 4.02 20.86 ± 1.66 < 0.0001 
FBG (mg/dL) 89.10 ± 1.23 88.55 ± 1.15 0.830 
Insulin (mU/L) 17.74 ± 1.88 11.27 ± 1.88 < 0.0001 
HOMA-IR 3.90 ± 2.04 1.46 ± 1.26 < 0.0001 
Resistin (pg/mL) 310.1 (1.07-1645.89) 313.35 (1.10-1835.99) 0.375 
BMI: Body Mass Index; FBG: Fasting Blood Glucose; HOMA-IR: Homeostatic Model 
Assessment-Insulin Resistance. Data were presented as the mean ± standard deviation 
for normally distributed data. Data were presented as median (minimum-maximum) for the 
data not normally distributed. 
 
The polymorphism of +299G > A RETN gene, 
frequency of GG, GA and AA genotypes were not 
significantly different (p = 0.429) and G allele 
compared to A allele between obese and control 
groups were not significantly different (p = 0.719). The 
frequency of CC genotype compared with other types 
(CG and GG) of -420 C > G RETN gene were not 
significantly different (p = 0.583) and C allele 
compared to G allele in obese, and control groups 
were not significantly different (p = 0.905) (Figure 1). 
 
Figure 1: Frequency of +299G > A and -420C > G genotypes and 
allele RETN gene in obese and control groups 
 
The association of resistin level with +299G > 
A and -420C > G RETN gene showed there were no 
significant differences in the obese and control groups 
(Table 2). 
Table 2: Level of Resistin in +299G>A and -420C>G RETN 
genotype in obese and control groups 
  Resistin level (pg/mL)  P 
+299G > A GG GA AA  
Obese 239.53 337.52 522.59 0.390 
(n = 71) (390.47) (555.75) (1079.84)  
Control 438.51 310.10 165.52 0.339 
(n = 71) (292.55) (562.05) (370.21)  
-420C > G CC CG GG  
Obese 168.42 310.10 310.45 0.722 
(n = 71) (708.32) (2508.71) (224.52)  
Control 376.27 336.62 82.89  
(n = 71) (373.33) (498.96) (149.44) 0.224 
Data presented as median (IQR) because the data was not normally distributed.  
 
The association between polymorphism of 
+299G > A and -420C > G RETN gene with insulin 
resistance showed GA genotypes compared with GG 
genotype were correlated with insulin resistance (p < 
0.001), as well as GA+AA genotype, was correlated 
with insulin resistance (p < 0.001). Polymorphism of -
420C > G RETN gene, however, was not correlated 
with insulin resistance (p > 0.05) (Table 3). 
 
 
Table 3: Association of +299G>A and -420C/G polymorphism of 
the RETN gene with insulin resistance 
+299 RETN gene (GG compared with 
GA, AA and GA+AA) 
Coefficient Odds 
Ratio 
95% CI for OR P 
GA 1.68 5.375 (2.20 - 13.13) < 0.001 
AA 2.13 8.437 (0.95 - 74.85) 0.055 
GA + AA 1.72 5.566 (2.31 - 13.44) < 0.001 
-420 RETN gene (CC compared with 
CG, GG and CG+GG) 
    
CG -0.43 0.649 (0.20, 2.09) 0.470 
GG -0.86 0.424 (0.10, 1.78) 0.240 
CG + GG -0.51 0.599 (0.19, 1.89) 0.383 
 
Serum resistin levels were significantly 
associated with insulin level with simple linear 
regression and had negative coefficient (p = 0.017), 
which indicated there were increases of resistin levels 
that were correlated with decreases of insulin level 
(Tables 4). 
Table 4: Simple linear regression of the variables with resistin 
level 
Variable Coefficient 95% CI P R
2 
BMI 2.24 (-8.84) – (13.32) 0.721 0.001 
Blood glucose 2.05 (-2.24) – (6.33) 0.342 0.007 
INSULIN -6.33 (-11.44) – (-1.16) 0.017 0.040 
HOMA-IR -19.13 (-39.94) - (1.69) 0.075 0.023 
 
 
 
Discussion 
 
The results of this study show there were 
significant differences in the levels of insulin and 
HOMA-IR between obese compared with the controls. 
The polymorphism of +299G > A RETN gene was 
correlated with insulin resistance but not for the -420C 
> G RETN gene. In the association of resistin level to 
insulin level and insulin resistance, we found serum 
resistin levels were significantly correlated with insulin 
level but for HOMA-IR index. 
HOMA-IR index in the obese group was 
higher than the control group like findings in some 
studies [5,15]. Resistin level between obese and 
control groups in this study did not differ significantly. 
This is in line with a study by Savage et al., found no 
relationship between adiposity and resistin mRNA 
expression in freshly adipocytes subjects with ranging 
BMI from 22 – 59 kg/m
2
 and insulin resistance [16]. 
Resistin gene in humans is on chromosome 19p13.3 
in an area that is not related to the vulnerability of 
obesity and insulin resistance [17]. 
One study by Kuminski [18] found expression 
of mRNA was not directly associated with expression 
of the protein, which, when modified both in the post-
transcriptional and post-translational process can 
influence resistin levels. The relationship between the 
expression and secretion of resistin and other 
inflammatory markers, including IL-6, C- reactive 
protein (CRP) were reported in patients with severe 
inflammatory diseases. Mild inflammation due to 
obesity will interfere with the level of resistin [19]. The 
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differences of this result with others are probably due 
to differences in obesity grouping [20]. Additionally, 
differences in the environmental factors may be 
affecting the HOMA-IR index. Polymorphism of +299G 
> A was associated with insulin resistance showing 
GA and GA+AA genotypes were risk factors for insulin 
resistance compared with GG genotype, but the 
polymorphism of -420C > G genotype was not a risk 
factor for insulin resistance. 
This finding was different from studies in 
Korea [21] and Thailand which showed no association 
between polymorphisms of +299G > A and -420C > G 
RETN gene with the parameters of the metabolic 
syndrome [8]. A Lebanon population showed +299G > 
A polymorphism was not involved in the pathogenesis 
of obesity and diabetes mellitus [17]. Research in 
Japan and Egypt indicated polymorphism of -420C > 
G RETN gene was associated with obesity [22], [23]. 
The differences in some of these studies may be 
because there were differences in ethnicity that cause 
unequal frequency in each population. 
Polymorphism of +299G > A and -420C > G 
RETN gene in this study was not associated with 
levels of resistin and is in line with research in China 
[24]. This result is in contrast with other studies 
showing this polymorphism is associated with 
increased levels of resistin in some East Asian 
populations, including Japanese, Korean, and 
Chinese, although data from the Caucasian 
population shows that this polymorphism is not 
associated with higher levels of resistin [1]. RETN 
polymorphism is correlated to increased BMI, blood 
pressure, fasting blood glucose, HOMA-IR, 
triglycerides, total cholesterol, resistin level, and 
decreased in HDL-cholesterol [5].  
The results of research in non-obese type 2 
diabetes mellitus patients showed the polymorphism 
of AA/AG genotypes of +299G > A RETN gene is 
considered as a risk factor for increased insulin 
resistance, based on fasting blood glucose and 
HOMA-IR index [13]. These results demonstrate 
ethnicity as a factor underlying the differences of 
SNPs in the influencing of human resistin expression 
[19]. In this study, polymorphism of +299G > A RETN 
gene was associated with insulin resistance. This 
result is similar to research in Iraq which showed that 
polymorphism RETN +299G > A gene plays a role in 
insulin resistance [25] and this polymorphism was 
found to increase the risk of diabetes mellitus in a 
population in Thailand [8]. Polymorphism of -420C > G 
RETN gene in this study was not associated with 
insulin resistance. This result is similar to a study in 
the Han population of China showing polymorphism of 
the RETN gene is not a risk factor for diabetes 
mellitus [26]. A study by Wen [27] in China reported 
the opposite results, finding this polymorphism 
increases the risk of diabetes mellitus. 
Obesity is a polygenic effect that is influenced 
by a combination of several genes and environmental 
factors. Frequency of RETN gene varies with ethnicity 
and environment. Exposure to different environments 
such as dietary habits and genetic background other 
than differences in study design may cause different 
effects on obesity [5]. These differences probably 
cause the different results in studies concerning the 
influence of the polymorphism of the RETN gene in 
the pathogenesis of obesity along with the small 
number of samples that might contribute to 
differences in results. Additional research is needed to 
identify factors associated with inflammation due to 
obesity and the correlation of resistin levels with 
polymorphisms of genes should be further 
investigated. 
In conclusion, polymorphism of +299G > A of 
RETN gene may be considered as a risk factor for 
insulin resistance but not the -420C > T of RETN 
gene. The level of resistin is correlated with the insulin 
level in Indonesia. 
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